SNSE
Price:
$0.5211
Market Cap:
$13.11M
Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune response; and Tumor Microenvironment Activated Biologics, a platform designed to unleash the anti-tumor potential of T-cells, as well as human monoclonal antibodies that are selectively active in the tumor microenvironment and target immune checkpoints or other critical immune pathways. The company also develops SNS-101, a monoclonal antibody for the tre...[Read more]
Industry
Biotechnology
IPO Date
2021-02-04
Stock Exchange
NASDAQ
Ticker
SNSE
According to Sensei Biotherapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 8.84. This represents a change of -19.13% compared to the average of 10.93 of the last 4 quarters.
The mean historical Current Ratio of Sensei Biotherapeutics, Inc. over the last ten years is 9.82. The current 8.84 Current Ratio has changed 8.90% with respect to the historical average. Over the past ten years (40 quarters), SNSE's Current Ratio was at its highest in in the March 2021 quarter at 69.81. The Current Ratio was at its lowest in in the March 2020 quarter at 0.
Average
9.82
Median
8.04
Minimum
0.02
Maximum
30.38
Discovering the peaks and valleys of Sensei Biotherapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 17.88%
Maximum Annual Current Ratio = 30.38
Minimum Annual Increase = -95.19%
Minimum Annual Current Ratio = 0.02
Year | Current Ratio | Change |
---|---|---|
2023 | 11.92 | -0.50% |
2022 | 11.98 | -60.58% |
2021 | 30.38 | 630.97% |
2020 | 4.16 | 17.88% |
2019 | 0.02 | -95.19% |
The current Current Ratio of Sensei Biotherapeutics, Inc. (SNSE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
18.09
5-year avg
11.69
10-year avg
9.82
Sensei Biotherapeutics, Inc.’s Current Ratio is greater than Landos Biopharma, Inc. (4.43), greater than Vor Biopharma Inc. (4.69), greater than Evaxion Biotech A/S (0), greater than Decibel Therapeutics, Inc. (4.81), greater than NexImmune, Inc. (0.66),
Company | Current Ratio | Market cap |
---|---|---|
4.43 | $71.68M | |
4.69 | $54.25M | |
0 | $8.06M | |
4.81 | $123.37M | |
0.66 | $488.13K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sensei Biotherapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sensei Biotherapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Sensei Biotherapeutics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Sensei Biotherapeutics, Inc. (SNSE)?
What is the highest Current Ratio for Sensei Biotherapeutics, Inc. (SNSE)?
What is the 3-year average Current Ratio for Sensei Biotherapeutics, Inc. (SNSE)?
What is the 5-year average Current Ratio for Sensei Biotherapeutics, Inc. (SNSE)?
How does the current Current Ratio for Sensei Biotherapeutics, Inc. (SNSE) compare to its historical average?